This is a review about HLA-DQB1, based on 1 published articles (read how Labome selects the articles), using HLA-DQB1 antibody in experiments. It is aimed to help Labome visitors find the most suited HLA-DQB1 antibody.
HLA-DQB1 synonym: CELIAC1; HLA-DQB; IDDM1; HLA class II histocompatibility antigen, DQ beta 1 chain; MHC DQ beta; MHC class II DQ beta chain; MHC class II HLA-DQ beta glycoprotein; MHC class II antigen DQB1; MHC class II antigen HLA-DQ-beta-1; MHC class2 antigen; lymphocyte antigen

Leica Microsystems
  • Novocastra Laboratories anti-HLA Class II (DR) was used to perform immunohistochemistry in order to show CD80 and CD86 may be potential nasopharyngeal carcinoma markers for clinical outcome.ncbi, more , figure 1
  • Figure 1
    HLA-DQB1 antibody immunohistochemistry Leica Microsystems
    HLA-DQB1 antibody immunohistochemistry Leica Microsystems
    Positive membrane staining of HLA-DR in undifferentiated carcinoma, 400 x (left); negative staining of HLA-DR in carcinoma cellsand dispersed lymphocytes with HLA-DR expression, 400 x (right).
    Cheng Shyong Chang et al. (2007). "Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma".PMID 17524139
suppliernum
Leica Microsystems1
Table 1. HLA-DQB1 antibody immunohistochemistry.
Articles Reviewed
  1. Cheng Shyong Chang et al. (2007). "Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma".PMID 17524139